<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Multiple chronic conditions
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Multiple chronic conditions
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Multiple chronic conditions
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Heather E Whitson, MD, MHS
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Cynthia M Boyd, MD, MPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kenneth E Schmader, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jane Givens, MD, MSCE
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jun 29, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H30994423">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Multimorbidity, also known as multiple comorbidities or multiple chronic conditions, is common and greatly increases the complexity of managing disease in patients. Worldwide, people are living longer with disability and multiple comorbidities, with important implications for global health care needs [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         This topic will discuss the challenges posed by managing patients with multiple chronic conditions and will present strategies to maximize effective care for such patients.
        </p>
        <p class="headingAnchor" id="H30629397">
         <span class="h1">
          TERMINOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Multimorbidity refers to the cooccurrence of two or more chronic medical or psychiatric conditions, which may or may not directly interact with each other [
         <a href="#rid2">
          2-4
         </a>
         ]. The term "multimorbidity" is sometimes used interchangeably with comorbidity [
         <a href="#rid5">
          5
         </a>
         ], but comorbidity technically indicates a condition or conditions that coexist in the context of an index disease [
         <a href="#rid6">
          6
         </a>
         ]. As an example, an oncologist may be concerned with the effect of comorbidity on the management of lung cancer, whereas multimorbidity captures the general complexity of patients without focusing on any single disease [
         <a href="#rid7">
          7,8
         </a>
         ].
        </p>
        <p>
         "Multiple chronic conditions" is a term closely related to multimorbidity. Several initiatives in the United States use this term in targeting a population for improving outcomes and care quality. The National Quality Forum defines multiple chronic conditions as "two or more chronic conditions that collectively have an adverse effect on health status, function, or quality of life and that require complex healthcare management, decision-making, or coordination" [
         <a href="#rid9">
          9
         </a>
         ]. This concept recognizes the marked heterogeneity within the large population of individuals with two or more chronic conditions. Hypertension and hypothyroidism, for example, do not generally encompass the same complexity or health needs as heart failure and dementia. Therefore, it can be beneficial to identify a subset of people with multiple chronic conditions that is in particular need of a different paradigm for care. Hereafter, we refer to the more basic definition of multimorbidity as two or more conditions, but we recognize that more nuanced definitions may better target interventions towards specific populations that need them.
        </p>
        <p class="headingAnchor" id="H30629384">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although exact prevalence estimates depend on the type and number of conditions considered in the definition of multimorbidity [
         <a href="#rid10">
          10,11
         </a>
         ], the presence of multiple chronic conditions is common [
         <a href="#rid12">
          12-14
         </a>
         ], and the number and proportion of patients with multiple chronic conditions is growing [
         <a href="#rid2">
          2,15
         </a>
         ]. A study of adults over age 65 in Alberta, Canada found that the prevalence of at least three morbidities was 34 percent, which rose to 50 percent over nine years [
         <a href="#rid16">
          16
         </a>
         ]. Although the prevalence of multimorbidity is highest among adults age 65 or older, younger persons also represent a large proportion of those with multimorbidity [
         <a href="#rid17">
          17-19
         </a>
         ]. In addition to age, lower socioeconomic status may be associated with a higher prevalence of multimorbidity, although data are scarce [
         <a href="#rid20">
          20
         </a>
         ].
        </p>
        <p>
         Because certain conditions heighten the risk of developing other conditions, people with multimorbidity are likely to accumulate more diagnoses and experience escalating clinical complexity [
         <a href="#rid7">
          7,21
         </a>
         ]. In one study that analyzed data from over 60,000 adults in the Netherlands and adjusted for age and insurance status, individuals with multimorbidity at baseline were 40 percent more likely than those without multimorbidity to be diagnosed with two or more new conditions during the next year [
         <a href="#rid22">
          22
         </a>
         ].
        </p>
        <p>
         Data from the United States National Health and Nutrition Examination Survey (NHANES) found that among 1259 individuals with coronary heart disease, coexisting noncardiac morbidities included arthritis (57 percent), chronic lung disease (25 percent), diabetes (25 percent), renal insufficiency (24 percent), and stroke (14 percent) [
         <a href="#rid23">
          23
         </a>
         ]. Functional issues included urinary incontinence (49 percent), mobility difficulty (40 percent), falls or dizziness (35 percent), and cognitive impairment (30 percent).
        </p>
        <p class="headingAnchor" id="H30994430">
         <span class="h1">
          IMPACT
         </span>
         <span class="headingEndMark">
          —
         </span>
         Multimorbidity is associated with high health care utilization and costs, especially among those with functional limitations [
         <a href="#rid21">
          21,24,25
         </a>
         ]. The two-thirds of Medicare beneficiaries with multimorbidity account for 96 percent of Medicare expenditures [
         <a href="#rid26">
          26
         </a>
         ].
        </p>
        <p>
         Individuals with multiple chronic conditions are at heightened risk of significant adverse health outcomes, often beyond the effects of the individual conditions [
         <a href="#rid16">
          16,21,27-36
         </a>
         ]. These include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Death
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Functional limitations and disability
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Frailty (see
         <a class="medical medical_review" href="/z/d/html/3010.html" rel="external">
          "Frailty"
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Nursing home placement
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Diminished quality of life
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Treatment complications
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Emergency department visits
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Adverse drug reactions
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hospitalizations, including avoidable admissions
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H30994437">
         <span class="h1">
          PATIENT CARE CHALLENGES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Clinicians and patients face many challenges in quality health care delivery. In focus group interviews, primary care clinicians in the United States identified multiple issues in providing care for patients with multimorbidity, including insufficient data about best practices, inadequate support and collaboration with specialists, conflicts between clinician and patient priorities, and reimbursement policies that don't adequately compensate for the effort involved in the management of complex patients [
         <a href="#rid37">
          37
         </a>
         ]. In a systematic review of 10 studies involving general practitioners in seven different countries, specific issues identified in managing patients with multimorbidity were: fragmentation of health care, inadequate guidelines and evidence-based medicine, and challenges delivering person-centered care and incorporating shared-decision making [
         <a href="#rid38">
          38
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H131371590">
         <span class="h2">
          Limitations of disease focused approach
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most treatments and practice guidelines target a single index condition, but patients with multimorbidity are complex and heterogeneous. The traditional disease-focused approach to clinical medicine may render care that is fragmented and poorly coordinated, and produce treatment plans that are inefficient, ineffective, or even harmful for patients with multimorbidity [
         <a href="#rid7">
          7,23,27,37,39-41
         </a>
         ]. Clinicians have limited guidance or evidence on which to base care decisions for such patients.
        </p>
        <p>
         Overlapping treatments can cause clinically relevant challenges. For example, a patient with early dementia may be prescribed
         <a class="drug drug_general" data-topicid="9383" href="/z/d/drug information/9383.html" rel="external">
          donepezil
         </a>
         , a cholinesterase inhibitor, which boosts levels of acetylcholine to improve their cognitive trajectory. However, if the same patient experiences urinary incontinence from overactive bladder, a different provider may prescribe
         <a class="drug drug_general" data-topicid="9728" href="/z/d/drug information/9728.html" rel="external">
          oxybutynin
         </a>
         or other anticholinergic. Now, this patient is taking a procholinergic medication for one problem (dementia) and an anticholinergic medication for another problem (overactive bladder). Another common problem is "therapeutic competition," which means that a medication prescribed for one condition is harmful or exacerbating for another condition. A common example of therapeutic competition is
         <a class="drug drug_general" data-topicid="10249" href="/z/d/drug information/10249.html" rel="external">
          rosiglitazone
         </a>
         prescribed for diabetes resulting in worsening heart failure symptoms [
         <a href="#rid42">
          42
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H30994444">
         <span class="h2">
          Adherence to multiple clinical practice guidelines
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most clinical practice guidelines are developed with the intent to address the diagnosis or management of a single clinical entity. The challenges and potential harm brought about by rigid adherence to clinical practice guidelines in patients with multimorbidity is illustrated in a paper that examined the hypothetical case of a 79-year-old woman with hypertension, diabetes mellitus, osteoporosis, osteoarthritis, and chronic obstructive pulmonary disease (COPD) [
         <a href="#rid41">
          41
         </a>
         ]. In following the most inexpensive and simple treatment plan that would satisfy all guidelines, the hypothetical patient would need to take 12 medications and, each year, follow 14 recommendations related to self-care or education, diagnostic testing, or referrals to other specialists or services  (
         <a class="graphic graphic_table graphicRef69591" href="/z/d/graphic/69591.html" rel="external">
          table 1
         </a>
         and
         <a class="graphic graphic_table graphicRef81404" href="/z/d/graphic/81404.html" rel="external">
          table 2
         </a>
         ). Furthermore, different guidelines may offer conflicting recommendations (eg, weightbearing exercise recommended by the osteoporosis guideline conflicts with cautions in weightbearing for neuropathic patients in the diabetes guideline) [
         <a href="#rid41">
          41
         </a>
         ].
        </p>
        <p>
         Although the applicability of most clinical practice guidelines to patients with multimorbidity is limited [
         <a href="#rid43">
          43,44
         </a>
         ], there are some that do recognize the need to adapt recommendations for patients with increased complexity. Specific steps have been described that may be considered to increase the relevance of guidelines to people with multiple comorbidities [
         <a href="#rid45">
          45-52
         </a>
         ]. As an example, the American Geriatrics Society (AGS) and American Diabetes Association's recommendations for the management of older patients with diabetes advocate for prioritization of goals of care among multiple conditions and recommend more permissive targets for glycemic control and blood pressure among patients with frailty or limited life expectancy [
         <a href="#rid53">
          53,54
         </a>
         ].
        </p>
        <p>
         The key to prioritizing among recommendations from multiple guidelines is in understanding what matters most to the patient, and what outcomes are most important or bothersome to the patient. Another important concept is time horizon to benefit, meaning how long it will take until benefits of interventions are achieved, and the net benefit across all benefit and harm outcomes relevant to the clinical question [
         <a href="#rid55">
          55,56
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H30994451">
         <span class="h2">
          Competing demands and shifting priorities
         </span>
         <span class="headingEndMark">
          —
         </span>
         Issues related to competing demands are common when caring for patients with multiple conditions. Patients with multimorbidity typically experience a fluctuating health status, with particular ailments rotating into and out of the forefront in terms of their influence on the patient's overall well-being [
         <a href="#rid57">
          57,58
         </a>
         ].
        </p>
        <p>
         To maximize quality of life, patients with multimorbidity must strike a daily balance between attending to their health problems, thereby controlling symptoms and reducing flares and complications while avoiding the potential for their lives to be ruled by the demands of chronic disease management [
         <a href="#rid57">
          57
         </a>
         ]. Clinicians' well-meaning attempts to aggressively treat all conditions all the time, without sufficient attention to the whole person and their shifting priorities, may result in treatment recommendations that the patient finds overwhelming, unaffordable, or otherwise unrealistic [
         <a href="#rid41">
          41
         </a>
         ].
        </p>
        <p>
         Clinicians themselves must balance competing demands for their time in attempting to address multiple health issues within the confines of a 15- to 20-minute office visit. By time constraints alone, a primary care provider in the United States with a standard patient panel may be unable to deliver the services recommended for chronic disease management and prevention [
         <a href="#rid59">
          59,60
         </a>
         ]. The situation is compounded when a treatment beneficial for one condition (eg, anticoagulation for atrial fibrillation) may lead to harm due to a concurrent condition (eg, bleeding from diverticulosis), forcing a prioritization of competing health objectives. Similarly, patients with multimorbidity and the clinicians who provide their care must prioritize conditions that require the most active management and balance treatment strategies consistent with the patient's preferences, tolerance, and needs.
        </p>
        <p class="headingAnchor" id="H30994459">
         <span class="h2">
          Polypharmacy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Medication use among older adults in the United States is high and continues to rise [
         <a href="#rid61">
          61
         </a>
         ]. Patients with more chronic conditions and more frequent clinical encounters take more medicines and are at the greatest risk of being prescribed potentially inappropriate medications [
         <a href="#rid62">
          62
         </a>
         ].
        </p>
        <p>
         Even when each medication has an appropriate indication, polypharmacy is associated with burden, cost, and risk of drug-drug or drug-condition interactions [
         <a href="#rid63">
          63,64
         </a>
         ]. The important issue of polypharmacy is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/3013.html" rel="external">
          "Drug prescribing for older adults", section on 'Polypharmacy'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/122694.html" rel="external">
          "Deprescribing"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H30994466">
         <span class="h2">
          Limited evidence
         </span>
         <span class="headingEndMark">
          —
         </span>
         A major challenge in delivering appropriate care to patients with multimorbidity stems from the fact that these complex patients are underrepresented in clinical research populations [
         <a href="#rid40">
          40,65
         </a>
         ]. Comorbidities are typically an exclusion factor for patient recruitment into studies addressing a given clinical condition. When investigators do attempt to include representative numbers of patients with multimorbidity in a clinical trial, they often face challenges in terms of recruitment and retention that lead to selection bias and large amounts of missing data [
         <a href="#rid66">
          66
         </a>
         ].
        </p>
        <p>
         As a result, the evidence base to guide medical decision-making for these patients is lacking [
         <a href="#rid41">
          41
         </a>
         ]. In the absence of trial data, providers cannot be certain how the presence of coexisting conditions may alter the tolerance or treatment effect of an intervention for a particular disease [
         <a href="#rid67">
          67
         </a>
         ]. Many pivotal trials lack generalizability to "real-world" patient populations who have significant complexity and morbidity burden. Despite strong evidence of efficacy in a trial population, clinicians at the bedside are left uncertain of the benefit (or harm) that an intervention offers to their patient [
         <a href="#rid68">
          68
         </a>
         ].
        </p>
        <p>
         A 2021 systematic review of 17 trials to improve outpatient management of patients with multimorbidities found little or no difference in clinical outcomes with small improvement in patient-reported outcomes among trials evaluating a variety of interventions focused either on care delivery (eg, through case management or enhanced multidisciplinary team work) or patient-oriented interventions (eg, education or self-management support) [
         <a href="#rid69">
          69
         </a>
         ].
        </p>
        <p>
         Finally, the heterogeneous nature of multimorbidity makes it difficult to control for confounding or to draw inferences about how a broad array of coexisting conditions may have impacted treatment effect [
         <a href="#rid70">
          70,71
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H30994473">
         <span class="h1">
          APPROACH TO THE PATIENT WITH MULTIMORBIDITY
         </span>
        </p>
        <p class="headingAnchor" id="H154647568">
         <span class="h2">
          Overall approach from expert group guidelines
         </span>
         <span class="headingEndMark">
          —
         </span>
         A panel convened by the American Geriatrics Society (AGS) has identified five guiding principles for management of multimorbidity  (
         <a class="graphic graphic_algorithm graphicRef86695" href="/z/d/graphic/86695.html" rel="external">
          algorithm 1
         </a>
         ) [
         <a href="#rid72">
          72
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Elicit and incorporate patient preferences into medical decision-making
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Recognize the limitations of the evidence base in interpreting and applying the medical literature to persons with multimorbidity
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Frame clinical management decisions within the context of risks, burdens, benefits, and prognosis (remaining life expectancy, functional status, quality of life)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Consider treatment complexity and feasibility when making clinical management decisions
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Choose therapies that optimize benefit, minimize harm, and enhance the quality of life
        </p>
        <p>
        </p>
        <p>
         In 2019, the AGS convened a second workgroup to translate these guiding principles into action [
         <a href="#rid73">
          73
         </a>
         ]. The multiple chronic condition action steps are summarized as follows:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Identify and communicate patients' health priorities and health trajectory
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Stop, start, or continue care based on health priorities, potential benefit versus harm and burden, and health trajectory
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Align decisions and care among patients, caregivers, and other clinicians with patients' health priorities and health trajectory
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         When considering disease-specific guidelines, these action steps are useful in the context of overall health status, considering the patient's life expectancy, degree of functional impairment, and chronic disease burden. The AGS advises the following approach:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For patients with &gt;10 years life expectancy, few chronic conditions, and none or few functional limitations, disease-specific guidelines should be utilized in accordance with patient preferences.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For patients with &lt;1 to 2 years life expectancy and advanced illness, guideline-specific care to aggressively treat and manage disease is often not best aligned with patient goals and preferences. Rather, care should focus on aggressive palliation of symptoms and a care plan that prioritizes quality over quantity of life.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For patients with 2 to 10 years life expectancy, an increasing number or severity of chronic conditions and functional impairment, the multiple chronic condition action steps should be utilized.
        </p>
        <p>
        </p>
        <p>
         Guidelines for management of multimorbidity have also been developed by the National Institute for Health and Care Excellence (NICE) in the United Kingdom [
         <a href="#rid74">
          74
         </a>
         ]. The guidelines advise:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Tailor care to meet personal goals and priorities
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Identify people who may benefit from care that takes into account multimorbidity by considering factors such as presence of frailty, falls, difficulty with daily activities or medication management, or need for multiple services or frequent use of emergency care
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Establish what is important to the patient
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Identify the impact of disease and treatment burden on quality of life
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Review medications: consider stopping nonessential treatment, consider nonpharmacologic approaches
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Develop an individualized management plan
        </p>
        <p>
        </p>
        <p>
         We have attempted to highlight key aspects of care delivery for those with multimorbidity that promote coordinated, safe, high-quality care in keeping with patient preferences and feasible within the current health care system, consistent with the AGS guiding principles.
        </p>
        <p class="headingAnchor" id="H30994480">
         <span class="h2">
          Elicit patient goals and priorities
         </span>
         <span class="headingEndMark">
          —
         </span>
         The Institute of Medicine's report, "Crossing the Quality Chasm," emphasized that the "true north" of quality in health care is the patient experience [
         <a href="#rid75">
          75
         </a>
         ]. This becomes all the more relevant for patients with multimorbidity, given the challenges of conflicting recommendations, competing demands, and limited evidence.
        </p>
        <p>
         To optimize care for the individual patient, a provider must understand the patient's goals and preferences and how their health relates to perceived roles within a family or community [
         <a href="#rid76">
          76
         </a>
         ]. The dialogue about patient goals and priorities includes a discussion of end-of-life preferences, as well as medical decision-making to include drug initiation and discontinuation, hospitalizations and procedures, receipt of preventive services, and recommendations for behavioral changes such dietary restrictions and frequency of blood pressure monitoring [
         <a href="#rid76">
          76
         </a>
         ]. For example, an older adult may prioritize the ability to live at home, walk their dog, eat what they want, or get down the steps in order to be able to go visit family. These priorities can and should inform decision-making. (See
         <a class="medical medical_review" href="/z/d/html/95552.html" rel="external">
          "Discussing goals of care"
         </a>
         .)
        </p>
        <p>
         Successful elicitation of patient preference requires that the patient and provider communicate effectively and that the patient has an adequate understanding of relevant choices and their expected outcomes. It is important to recognize that patients with multimorbidity frequently have impairments in hearing, vision, or cognition that may restrict communication or their capacity to process information. Special measures may be necessary to overcome the barriers associated with these impairments  (
         <a class="graphic graphic_table graphicRef58401" href="/z/d/graphic/58401.html" rel="external">
          table 3
         </a>
         ).
        </p>
        <p>
         Even in patients without known communication barriers, there is considerable variability in individual's comfort level and desire to engage in the medical decision-making process [
         <a href="#rid77">
          77
         </a>
         ]. Approaches to enhancing patient involvement need to be flexible. Factors implicated in successful patient engagement include communication skills of the provider, trust in the relationship, and adequate time [
         <a href="#rid77">
          77
         </a>
         ]. When available, a referral for Comprehensive Geriatric Assessment may be a useful means of clarifying goals and priorities for patients with multimorbidity. (See
         <a class="medical medical_review" href="/z/d/html/3009.html" rel="external">
          "Comprehensive geriatric assessment"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H30994487">
         <span class="h2">
          Coordination of care
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with multimorbidity experience frequent clinical encounters, often with multiple providers representing different disciplines across many health care settings (including outpatient, inpatient, emergency department, long-term or rehabilitation facilities, and in-home care) [
         <a href="#rid75">
          75,78
         </a>
         ]. Transitions of care have been identified as a high-risk opportunity for medical errors, particularly for complex patients [
         <a href="#rid79">
          79-81
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2790.html" rel="external">
          "Hospital discharge and readmission", section on 'Failed handoffs'
         </a>
         .)
        </p>
        <p>
         Inconsistent recommendations or duplicative care from various providers can result in patient confusion, unnecessary cost, and treatment burden resulting in poor quality of care [
         <a href="#rid82">
          82,83
         </a>
         ]. An essential component of high-quality care for patients with multimorbidity is coordination of a uniform care plan that is communicated across settings, providers, and caregivers.
        </p>
        <p>
         Electronic health records are helpful in coordinating care because they facilitate access to and sharing of information between various providers [
         <a href="#rid84">
          84,85
         </a>
         ]. For particularly complex medical decisions, direct communication among providers, patients, and caregivers is often the best means of filling in knowledge gaps or arriving at a consensus. Multidisciplinary forums, such as tumor boards or stroke teams, may provide regular opportunities for discussion of patients by multiple providers involved in a certain aspect of patient care.
        </p>
        <p>
         The time constraints of most clinical practices and the fragmented, disease-focused nature of service provision make it challenging to coordinate an overall care plan effectively in the current health care system. Case managers and extended care providers may play an essential role in coordinating care for the most complicated and vulnerable patients within a practice [
         <a href="#rid86">
          86,87
         </a>
         ].
        </p>
        <p>
         In addition, the value of informal, unpaid caregivers (family and friends) is increasingly recognized, particularly in the care of patients with multimorbidity [
         <a href="#rid88">
          88
         </a>
         ]. Nonprofessional caregivers influence adherence and decision-making, supplement self-care, and frequently accompany patients to office visits [
         <a href="#rid88">
          88-90
         </a>
         ]. Although questions remain about how to optimally engage and integrate this support network, such caregivers are often instrumental in managing "the big picture" for patients with multimorbidity [
         <a href="#rid91">
          91,92
         </a>
         ].
        </p>
        <p>
         Innovative models show promise in their ability to promote more seamless, efficient, and holistic care for older adults with multimorbidity. These programs often incorporate many aspects of the Wagner Chronic Care model, which emphasizes system elements that promote coordinated care by creating partnerships among patients, their families and informal caregivers, and providers [
         <a href="#rid93">
          93-95
         </a>
         ]. Examples of these models of care include Guided Care [
         <a href="#rid96">
          96-98
         </a>
         ], the Program of All-Inclusive Care of the Elderly (PACE) [
         <a href="#rid99">
          99
         </a>
         ], Geriatric Resources for Assessment and Care of Elders (GRACE) [
         <a href="#rid100">
          100
         </a>
         ], and the Patient-Centered Medical Home [
         <a href="#rid101">
          101
         </a>
         ].
        </p>
        <p>
         Integrated care, involving both psychiatric and medical specialty providers, to address the medical conditions and depression that frequently coexist in older patients with chronic medical problems can improve quality of life and disability outcomes [
         <a href="#rid102">
          102
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H30994494">
         <span class="h2">
          Less may be best
         </span>
         <span class="headingEndMark">
          —
         </span>
         Every intervention, hospitalization, or medication prescribed creates the potential for harm. These risks are magnified in patients with multimorbidity.
        </p>
        <p class="headingAnchor" id="H1618789803">
         <span class="h3">
          Treatment goals
         </span>
         <span class="headingEndMark">
          —
         </span>
         Careful consideration should be given to each treatment decision and how it figures into the patient's preferences and overall equation of potential benefit versus burden and risk. The specific examples of diabetes and hypertension are discussed below. (See
         <a class="local">
          'Common disease-specific considerations'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H4021257053">
         <span class="h3">
          Cancer screening
         </span>
         <span class="headingEndMark">
          —
         </span>
         Preventive practices such as cancer screening should remain relevant and appropriate for patients with multiple chronic conditions [
         <a href="#rid103">
          103,104
         </a>
         ]. Cancer screening in patients with limited life expectancy is associated with unfavorable risk to benefit ratios, especially in patients with less than a five-year life expectancy or in those who would decline treatment if disease is identified [
         <a href="#rid105">
          105-107
         </a>
         ]. The types and severity of comorbid conditions present can help guide estimates of life expectancy and inform personalized decisions about when to cease routine cancer screening  (
         <a class="graphic graphic_table graphicRef96330" href="/z/d/graphic/96330.html" rel="external">
          table 4
         </a>
         ) [
         <a href="#rid105">
          105
         </a>
         ]. Tools are available to estimate life expectancy (eg,
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Feprognosis.ucsf.edu%2Findex.php&amp;token=io%2FPsaQQZxDpnBUAopDlb55YcUcsl9c5V%2FYzjKKFt2rxhAug2aBkgewCwyK5I3Sh&amp;TOPIC_ID=16526" target="_blank">
          ePrognosis
         </a>
         ). Overall, the patient's preferences, as well as the patient's overall health, should inform decision-making.
        </p>
        <p class="headingAnchor" id="H2669277826">
         <span class="h3">
          Medication considerations
         </span>
         <span class="headingEndMark">
          —
         </span>
         A concept of "time to benefit" (TTB) has been considered in relation to drug prescribing for patients who have multiple morbidities and also may have limited life expectancies [
         <a href="#rid108">
          108
         </a>
         ]. This concept has also been identified as "time horizon to benefit" [
         <a href="#rid72">
          72
         </a>
         ]. TTB, defined as the time to significant benefit observed in trials of people treated with a drug compared with controls, can be estimated from data from randomized controlled trials. Such information may help guide decision-making for drug prescribing in individual patients, although it should be recognized that patients with multimorbidity are often excluded from randomized trials.
        </p>
        <p>
         To minimize inappropriate prescribing and adverse drug reactions in patients with multimorbidity, we recommend the following general strategies:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Start low, go slow with any medication initiation or dose change.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Always ask, "Can this problem or symptom be addressed without my prescription pad?" For example:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Can sleep disturbance be addressed with sleep hygiene and behavioral changes?
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Could incontinence be addressed with scheduled voiding and referral to urogynecological rehabilitation specialist?
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Could reflux be addressed with dietary changes and elevation of the head of the bed?
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Can ankle edema be addressed with leg elevation and compression stockings?
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Frequent review of medication list for appropriateness in the context of patient's current goals and preferences, with consideration of deprescribing as necessary. (See
         <a class="medical medical_review" href="/z/d/html/122694.html" rel="external">
          "Deprescribing"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Consolidate drug dosing schedules to minimize complexity and chance of error. The Institute of Medicine has proposed a standardized schedule for specifying medication dosing (morning, noon, evening, bedtime), recognizing that 90 percent of prescriptions are taken four or fewer times daily [
         <a href="#rid109">
          109
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Consolidate treatments when possible (ie, angiotensin-converting enzyme [ACE] inhibitor for blood pressure, renal protection, and heart failure).
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H30994501">
         <span class="h2">
          Identify and address issues that impact multiple conditions
         </span>
         <span class="headingEndMark">
          —
         </span>
         One efficient way to promote better outcomes for patients with multimorbidity is to identify issues that affect a patient's well-being or quality of life in ways that cut across many diseases. Examples of these issues include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Nutrition
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Physical activity/exercise
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Function/independence
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sleep disturbance
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Mental health
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Safety of environment and adequacy of support in current level of care
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Caregiver stress [
         <a href="#rid110">
          110
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H624058">
         <span class="h2">
          Common disease-specific considerations
         </span>
         <span class="headingEndMark">
          —
         </span>
         Even in patients with multimorbidity, it is sometimes appropriate to apply typical management strategies to individual chronic conditions. For example, aggressive management of heart failure may be necessary to prevent exacerbations and frequent hospitalizations. Patients with a history of myocardial infarction (MI) should receive a trial of beta blockers, even in the setting of comorbid chronic obstructive pulmonary disease (COPD), because many patients with COPD tolerate beta blockers and the treatment benefit of beta blockers post-MI is clear. (See
         <a class="medical medical_review" href="/z/d/html/96.html" rel="external">
          "Acute myocardial infarction: Role of beta blocker therapy"
         </a>
         .)
        </p>
        <p>
         However, the presence of comorbidity frequently dictates the need to adjust the treatment plans for individual conditions. Due to the heterogeneity of comorbidities that may coexist with any condition, it is not feasible to provide a uniform set of guidelines for the management of a specific disease in patients with multimorbidity. The guiding principle in patients with multimorbidity should be individualization of treatment. We have highlighted frequent considerations that arise in the setting of two common comorbidities, which may justify departure from rigid adherence to disease-specific guidelines.
        </p>
        <p class="headingAnchor" id="H624113">
         <span class="h3">
          Diabetes
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The appropriate target for glycated hemoglobin (A1C) should be individualized based on life expectancy and comorbidity burden  (
         <a class="graphic graphic_table graphicRef117873" href="/z/d/graphic/117873.html" rel="external">
          table 5
         </a>
         ). A target of 8 percent is appropriate in persons with limited life expectancy or persons in whom the risks of hypoglycemia outweigh the benefit of more aggressive targets (eg, persons who have difficulty maintaining consistent caloric intake due to gastrointestinal comorbidities or conditions that cause frequent nausea or anorexia) [
         <a href="#rid53">
          53,54
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/1776.html" rel="external">
          "Treatment of type 2 diabetes mellitus in the older patient"
         </a>
         ). Further, the American College of Physicians recommends avoiding a target HbA1c level altogether in patients with a life expectancy less than 10 years, and treating only to minimize symptoms [
         <a href="#rid111">
          111
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Insulin therapy may be inappropriate in patients with cognitive or visual impairments that increase the risk of medication error, unless the patient has a caregiver with the ability to assist with every insulin dose.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The risk of hypoglycemia is increased in older adults, particularly those with comorbidities. Thus, when possible, therapeutic agents should be selected that have a lower risk for hypoglycemia (eg,
         <a class="drug drug_general" data-topicid="9621" href="/z/d/drug information/9621.html" rel="external">
          metformin
         </a>
         , shorter-acting sulfonylurea, or
         <a class="drug drug_general" data-topicid="9604" href="/z/d/drug information/9604.html" rel="external">
          repaglinide
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The value of self-monitoring blood glucose (SMBG) in patients with type 2 diabetes who are diet-treated or treated with oral agents that are not associated with hypoglycemia is not as clear as for other diabetic patients. Thus, advice regarding SMBG for older diabetic patients, and especially those with comorbidity, should be tailored to the patient, based upon medications and functional and cognitive abilities.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Electrolytes and renal function should be assessed within one to two weeks of initiation or dose adjustments of ACE inhibitors, angiotensin II receptor blockers (ARBs), or diuretics, due to the increased likelihood of adverse effects in patients with multimorbidity [
         <a href="#rid112">
          112
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H624140">
         <span class="h3">
          Hypertension
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A less aggressive systolic goal blood pressure may be appropriate for patients with limited life expectancy. (See
         <a class="medical medical_review" href="/z/d/html/3861.html" rel="external">
          "Goal blood pressure in adults with hypertension"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3863.html" rel="external">
          "Treatment of hypertension in older adults, particularly isolated systolic hypertension"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         All patients should receive nonpharmacologic therapy, particularly dietary salt restriction and weight loss in obese patients. Drug therapy should be started if lifestyle changes are not sufficient.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Blood pressure should be reduced gradually. Tolerance to blood pressure reduction should be assessed at regular intervals with attention to orthostasis, postprandial hypotension, falls, and activity restriction due to dizziness. More permissive blood pressure targets are appropriate, if patient preferences favor quality of life over potential benefit of additional blood pressure reduction. (See
         <a class="medical medical_review" href="/z/d/html/3863.html" rel="external">
          "Treatment of hypertension in older adults, particularly isolated systolic hypertension", section on 'Goal blood pressure'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Comorbidities should guide choice of agent. The goal is to avoid exacerbating comorbid conditions (eg, discontinue beta blockers if they worsen reactive airway disease or diuretics if they exacerbate urinary incontinence) and to minimize polypharmacy (eg, choose an alpha blocker to simultaneously address benign prostatic hypertrophy and hypertension, rather than prescribing a separate medication for each condition). (See
         <a class="medical medical_review" href="/z/d/html/3869.html" rel="external">
          "Choice of drug therapy in primary (essential) hypertension"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H248874169">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or email these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/83813.html" rel="external">
          "Patient education: When you have depression and another health problem (The Basics)"
         </a>
         and
         <a class="medical medical_basics" href="/z/d/html/16625.html" rel="external">
          "Patient education: Taking medicines when you're older (The Basics)"
         </a>
         and
         <a class="medical medical_basics" href="/z/d/html/86146.html" rel="external">
          "Patient education: When you have multiple health problems (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H30020203">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Terminology and impact
         </strong>
         – Multimorbidity, the cooccurrence of two or more medical or psychiatric conditions, occurs in patients of all ages and is increasingly prevalent with advancing age. Multiple chronic conditions is a closely related term. Patients with these conditions are more likely to have poor health outcomes and significant health care expenditures. (See
         <a class="local">
          'Terminology'
         </a>
         above and
         <a class="local">
          'Impact'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Patient care challenges
         </strong>
         – The challenges of managing patients with multimorbidity are multiple. They include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Lack of guidelines that are applicable to these complex patients
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Conflicting recommendations that arise in trying to apply guidelines developed for single disease entities
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Competing and shifting patient priorities of conditions to be addressed
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Risks associated with polypharmacy
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Lack of evidence on how best to treat patients with multimorbidity (see
         <a class="local">
          'Patient care challenges'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Guidelines from expert groups
         </strong>
         – Expert groups have developed principles and guidelines for care of these patients centered around an understanding of patient preferences and shared decision-making. (See
         <a class="local">
          'Overall approach from expert group guidelines'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Our approach
         </strong>
         – Key principles in caring for patients with multiple chronic conditions include (see
         <a class="local">
          'Approach to the patient with multimorbidity'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Attention to understanding a patient's goals of treatment and health care priorities. (See
         <a class="local">
          'Elicit patient goals and priorities'
         </a>
         above.)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Communication between the multiple providers, health care facilities, and caregivers involved in a patient's treatment. (See
         <a class="local">
          'Coordination of care'
         </a>
         above.)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Recognition of the potential harms associated with medical interventions. (See
         <a class="local">
          'Less may be best'
         </a>
         above.)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Minimizing drug dosing and complexity. (See
         <a class="local">
          'Medication considerations'
         </a>
         above.)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Identifying and addressing lifestyle and psychosocial issues that may affect the patient's quality of life and response to medical care. (See
         <a class="local">
          'Identify and address issues that impact multiple conditions'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Patients with diabetes or hypertension
         </strong>
         – The presence of comorbidity frequently dictates the need to adjust the treatment plans for individual conditions, such as diabetes of hypertension. (See
         <a class="local">
          'Common disease-specific considerations'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 386:743.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Uijen AA, van de Lisdonk EH. Multimorbidity in primary care: prevalence and trend over the last 20 years. Eur J Gen Pract 2008; 14 Suppl 1:28.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fortin M, Hudon C, Haggerty J, et al. Prevalence estimates of multimorbidity: a comparative study of two sources. BMC Health Serv Res 2010; 10:111.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mercer SW, Smith SM, Wyke S, et al. Multimorbidity in primary care: developing the research agenda. Fam Pract 2009; 26:79.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fried LP, Ferrucci L, Darer J, et al. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 2004; 59:255.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yancik R, Ershler W, Satariano W, et al. Report of the national institute on aging task force on comorbidity. J Gerontol A Biol Sci Med Sci 2007; 62:275.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boyd CM, Fortin M. Future of multimorbidity research: How should understanding of multimorbidity inform health system design? Public Health Reviews 2010; 32:451.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boyd CM, Ritchie CS, Tipton EF, et al. From Bedside to Bench: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Comorbidity and Multiple Morbidity in Older Adults. Aging Clin Exp Res 2008; 20:181.
          </a>
         </li>
         <li class="breakAll">
          Centers for Medicare and Medicaid Services. Multiple chronic conditions measures. Available at: https://www.cms.gov/files/document/blueprint-multiple-chronic-condition-measures.pdf (Accessed on October 08, 2021).
         </li>
         <li>
          <a class="nounderline abstract_t">
           van den Akker M, Buntinx F, Roos S, Knottnerus JA. Problems in determining occurrence rates of multimorbidity. J Clin Epidemiol 2001; 54:675.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fortin M, Bravo G, Hudon C, et al. Prevalence of multimorbidity among adults seen in family practice. Ann Fam Med 2005; 3:223.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Griffith LE, Gilsing A, Mangin D, et al. Multimorbidity Frameworks Impact Prevalence and Relationships with Patient-Important Outcomes. J Am Geriatr Soc 2019; 67:1632.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vetrano DL, Palmer K, Marengoni A, et al. Frailty and Multimorbidity: A Systematic Review and Meta-analysis. J Gerontol A Biol Sci Med Sci 2019; 74:659.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nicholson K, Almirall J, Fortin M. The measurement of multimorbidity. Health Psychol 2019; 38:783.
          </a>
         </li>
         <li class="breakAll">
          US Department of Health and Human Services. Multiple chronic conditions: A strategic framework - optimum health and quality of life for individuals with multiple chronic conditions. 2010. Available at: https://www.hhs.gov/sites/default/files/ash/initiatives/mcc/mcc_framework.pdf (Accessed on October 19, 2011).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tonelli M, Wiebe N, Straus S, et al. Multimorbidity, dementia and health care in older people:a population-based cohort study. CMAJ Open 2017; 5:E623.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barnett K, Mercer SW, Norbury M, et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 2012; 380:37.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rocca WA, Boyd CM, Grossardt BR, et al. Prevalence of multimorbidity in a geographically defined American population: patterns by age, sex, and race/ethnicity. Mayo Clin Proc 2014; 89:1336.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maciejewski ML, Hammill BG. Measuring the burden of multimorbidity among Medicare beneficiaries via condition counts and cumulative duration. Health Serv Res 2019; 54:484.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pathirana TI, Jackson CA. Socioeconomic status and multimorbidity: a systematic review and meta-analysis. Aust N Z J Public Health 2018; 42:186.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med 2002; 162:2269.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van den Akker M, Buntinx F, Metsemakers JF, et al. Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol 1998; 51:367.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boyd CM, Leff B, Wolff JL, et al. Informing clinical practice guideline development and implementation: prevalence of coexisting conditions among adults with coronary heart disease. J Am Geriatr Soc 2011; 59:797.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thorpe KE, Ogden LL, Galactionova K. Chronic conditions account for rise in Medicare spending from 1987 to 2006. Health Aff (Millwood) 2010; 29:718.
          </a>
         </li>
         <li class="breakAll">
          Komisar HL, Feder J. Transforming care for Medicare beneficiaries with chronic conditions and long-term care needs: coordinating care across all services. Georgetown University 2011. Available at: http://www.thescanfoundation.org/sites/default/files/Georgetown_Trnsfrming_Care.pdf (Accessed on October 21, 2014).
         </li>
         <li class="breakAll">
          Partnership for Solutions. Chronic conditions: Making the case for ongoing care. Johns Hopkins and the Robert Wood Johnson Foundation 2004. Available at: http://www.partnershipforsolutions.org/DMS/files/chronicbook2004.pdf (Accessed on October 19, 2011).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fortin M, Soubhi H, Hudon C, et al. Multimorbidity's many challenges. BMJ 2007; 334:1016.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fillenbaum GG, Pieper CF, Cohen HJ, et al. Comorbidity of five chronic health conditions in elderly community residents: determinants and impact on mortality. J Gerontol A Biol Sci Med Sci 2000; 55:M84.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fried LP, Bandeen-Roche K, Kasper JD, Guralnik JM. Association of comorbidity with disability in older women: the Women's Health and Aging Study. J Clin Epidemiol 1999; 52:27.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cornoni-Huntley JC, Foley DJ, Guralnik JM. Co-morbidity analysis: a strategy for understanding mortality, disability and use of health care facilities of older people. Int J Epidemiol 1991; 20 Suppl 1:S8.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fortin M, Bravo G, Hudon C, et al. Relationship between multimorbidity and health-related quality of life of patients in primary care. Qual Life Res 2006; 15:83.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marengoni A, von Strauss E, Rizzuto D, et al. The impact of chronic multimorbidity and disability on functional decline and survival in elderly persons. A community-based, longitudinal study. J Intern Med 2009; 265:288.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Glynn LG, Valderas JM, Healy P, et al. The prevalence of multimorbidity in primary care and its effect on health care utilization and cost. Fam Pract 2011; 28:516.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schneider KM, O'Donnell BE, Dean D. Prevalence of multiple chronic conditions in the United States' Medicare population. Health Qual Life Outcomes 2009; 7:82.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Whitson HE, Cousins SW, Burchett BM, et al. The combined effect of visual impairment and cognitive impairment on disability in older people. J Am Geriatr Soc 2007; 55:885.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vogeli C, Shields AE, Lee TA, et al. Multiple chronic conditions: prevalence, health consequences, and implications for quality, care management, and costs. J Gen Intern Med 2007; 22 Suppl 3:391.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fried TR, Tinetti ME, Iannone L. Primary care clinicians' experiences with treatment decision making for older persons with multiple conditions. Arch Intern Med 2011; 171:75.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sinnott C, Mc Hugh S, Browne J, Bradley C. GPs' perspectives on the management of patients with multimorbidity: systematic review and synthesis of qualitative research. BMJ Open 2013; 3:e003610.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tinetti ME, Fried T. The end of the disease era. Am J Med 2004; 116:179.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parekh AK, Barton MB. The challenge of multiple comorbidity for the US health care system. JAMA 2010; 303:1303.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005; 294:716.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Salive ME. Future Research Directions for Multimorbidity Involving Cardiovascular Diseases. Clin Geriatr Med 2016; 32:399.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tinetti ME, Bogardus ST Jr, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med 2004; 351:2870.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Safford MM, Allison JJ, Kiefe CI. Patient complexity: more than comorbidity. the vector model of complexity. J Gen Intern Med 2007; 22 Suppl 3:382.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goodman RA, Boyd C, Tinetti ME, et al. IOM and DHHS meeting on making clinical practice guidelines appropriate for patients with multiple chronic conditions. Ann Fam Med 2014; 12:256.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boyd CM, Kent DM. Evidence-based medicine and the hard problem of multimorbidity. J Gen Intern Med 2014; 29:552.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Uhlig K, Leff B, Kent D, et al. A framework for crafting clinical practice guidelines that are relevant to the care and management of people with multimorbidity. J Gen Intern Med 2014; 29:670.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Trikalinos TA, Segal JB, Boyd CM. Addressing multimorbidity in evidence integration and synthesis. J Gen Intern Med 2014; 29:661.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weiss CO, Varadhan R, Puhan MA, et al. Multimorbidity and evidence generation. J Gen Intern Med 2014; 29:653.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Putcha N, Puhan MA, Hansel NN, et al. Impact of co-morbidities on self-rated health in self-reported COPD: an analysis of NHANES 2001-2008. COPD 2013; 10:324.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fabbri LM, Boyd C, Boschetto P, et al. How to integrate multiple comorbidities in guideline development: article 10 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proc Am Thorac Soc 2012; 9:274.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boyd CM, Vollenweider D, Puhan MA. Informing evidence-based decision-making for patients with comorbidity: availability of necessary information in clinical trials for chronic diseases. PLoS One 2012; 7:e41601.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kirkman MS, Briscoe VJ, Clark N, et al. Diabetes in older adults: a consensus report. J Am Geriatr Soc 2012; 60:2342.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015; 38:140.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aschmann HE, Boyd CM, Robbins CW, et al. Informing Patient-Centered Care Through Stakeholder Engagement and Highly Stratified Quantitative Benefit-Harm Assessments. Value Health 2020; 23:616.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yourman LC, Cenzer IS, Boscardin WJ, et al. Evaluation of Time to Benefit of Statins for the Primary Prevention of Cardiovascular Events in Adults Aged 50 to 75 Years: A Meta-analysis. JAMA Intern Med 2021; 181:179.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morris RL, Sanders C, Kennedy AP, Rogers A. Shifting priorities in multimorbidity: a longitudinal qualitative study of patient's prioritization of multiple conditions. Chronic Illn 2011; 7:147.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Whitson HE, Steinhauser K, Ammarell N, et al. Categorizing the effect of comorbidity: a qualitative study of individuals' experiences in a low-vision rehabilitation program. J Am Geriatr Soc 2011; 59:1802.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yarnall KS, Pollak KI, Østbye T, et al. Primary care: is there enough time for prevention? Am J Public Health 2003; 93:635.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Østbye T, Yarnall KS, Krause KM, et al. Is there time for management of patients with chronic diseases in primary care? Ann Fam Med 2005; 3:209.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Charlesworth CJ, Smit E, Lee DS, et al. Polypharmacy Among Adults Aged 65 Years and Older in the United States: 1988-2010. J Gerontol A Biol Sci Med Sci 2015; 70:989.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fick DM, Waller JL, Maclean JR, et al. Potentially inappropriate medication use: Prevalence and association with resource utilization in an elderly managed care population. J Managed Care Pharm 2001; 7:407.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007; 5:345.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grundy SM. Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy. Nat Rev Drug Discov 2006; 5:295.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Knottnerus JA, Dinant GJ. Medicine based evidence, a prerequisite for evidence based medicine. BMJ 1997; 315:1109.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hardy SE, Allore H, Studenski SA. Missing data: a special challenge in aging research. J Am Geriatr Soc 2009; 57:722.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fortin M, Dionne J, Pinho G, et al. Randomized controlled trials: do they have external validity for patients with multiple comorbidities? Ann Fam Med 2006; 4:104.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hanlon P, Hannigan L, Rodriguez-Perez J, et al. Representation of people with comorbidity and multimorbidity in clinical trials of novel drug therapies: an individual-level participant data analysis. BMC Med 2019; 17:201.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith SM, Wallace E, O'Dowd T, Fortin M. Interventions for improving outcomes in patients with multimorbidity in primary care and community settings. Cochrane Database Syst Rev 2021; 1:CD006560.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lash TL, Mor V, Wieland D, et al. Methodology, design, and analytic techniques to address measurement of comorbid disease. J Gerontol A Biol Sci Med Sci 2007; 62:281.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Satariano WA, Silliman RA. Comorbidity: implications for research and practice in geriatric oncology. Crit Rev Oncol Hematol 2003; 48:239.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guiding principles for the care of older adults with multimorbidity: an approach for clinicians. Guiding principles for the care of older adults with multimorbidity: an approach for clinicians: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity. J Am Geriatr Soc 2012; 60:E1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boyd C, Smith CD, Masoudi FA, et al. Decision Making for Older Adults With Multiple Chronic Conditions: Executive Summary for the American Geriatrics Society Guiding Principles on the Care of Older Adults With Multimorbidity. J Am Geriatr Soc 2019; 67:665.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Farmer C, Fenu E, O'Flynn N, Guthrie B. Clinical assessment and management of multimorbidity: summary of NICE guidance. BMJ 2016; 354:i4843.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berwick DM. A user's manual for the IOM's 'Quality Chasm' report. Health Aff (Millwood) 2002; 21:80.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stewart M, Brown JB, Donner A, et al. The impact of patient-centered care on outcomes. J Fam Pract 2000; 49:796.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Belcher VN, Fried TR, Agostini JV, Tinetti ME. Views of older adults on patient participation in medication-related decision making. J Gen Intern Med 2006; 21:298.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reuben DB. Better ways to care for older persons: is anybody listening? J Am Geriatr Soc 2009; 57:2348.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coleman EA, Parry C, Chalmers S, Min SJ. The care transitions intervention: results of a randomized controlled trial. Arch Intern Med 2006; 166:1822.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boockvar K, Fishman E, Kyriacou CK, et al. Adverse events due to discontinuations in drug use and dose changes in patients transferred between acute and long-term care facilities. Arch Intern Med 2004; 164:545.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moore C, Wisnivesky J, Williams S, McGinn T. Medical errors related to discontinuity of care from an inpatient to an outpatient setting. J Gen Intern Med 2003; 18:646.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coleman EA. Falling through the cracks: challenges and opportunities for improving transitional care for persons with continuous complex care needs. J Am Geriatr Soc 2003; 51:549.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harrison A, Verhoef M. Understanding coordination of care from the consumer's perspective in a regional health system. Health Serv Res 2002; 37:1031.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chaudhry B, Wang J, Wu S, et al. Systematic review: impact of health information technology on quality, efficiency, and costs of medical care. Ann Intern Med 2006; 144:742.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blumenthal D, Glaser JP. Information technology comes to medicine. N Engl J Med 2007; 356:2527.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McAllister JW, Presler E, Cooley WC. Practice-based care coordination: a medical home essential. Pediatrics 2007; 120:e723.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boult C, Rassen J, Rassen A, et al. The effect of case management on the costs of health care for enrollees in Medicare Plus Choice plans: a randomized trial. J Am Geriatr Soc 2000; 48:996.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wolff JL, Roter DL. Hidden in plain sight: medical visit companions as a resource for vulnerable older adults. Arch Intern Med 2008; 168:1409.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Soubhi H, Fortin M, Hudon C. Perceived conflict in the couple and chronic illness management: preliminary analyses from the Quebec Health Survey. BMC Fam Pract 2006; 7:59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosland AM, Heisler M, Choi HJ, et al. Family influences on self-management among functionally independent adults with diabetes or heart failure: do family members hinder as much as they help? Chronic Illn 2010; 6:22.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mitnick S, Leffler C, Hood VL, American College of Physicians Ethics, Professionalism and Human Rights Committee. Family caregivers, patients and physicians: ethical guidance to optimize relationships. J Gen Intern Med 2010; 25:255.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wolff JL, Roter DL, Given B, Gitlin LN. Optimizing patient and family involvement in geriatric home care. J Healthc Qual 2009; 31:24.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wagner EH. Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract 1998; 1:2.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boult C, Wieland GD. Comprehensive primary care for older patients with multiple chronic conditions: "Nobody rushes you through". JAMA 2010; 304:1936.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Freund T, Peters-Klimm F, Boyd CM, et al. Medical Assistant-Based Care Management for High-Risk Patients in Small Primary Care Practices: A Cluster Randomized Clinical Trial. Ann Intern Med 2016; 164:323.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boyd CM, Boult C, Shadmi E, et al. Guided care for multimorbid older adults. Gerontologist 2007; 47:697.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boyd CM, Reider L, Frey K, et al. The effects of guided care on the perceived quality of health care for multi-morbid older persons: 18-month outcomes from a cluster-randomized controlled trial. J Gen Intern Med 2010; 25:235.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boult C, Reider L, Leff B, et al. The effect of guided care teams on the use of health services: results from a cluster-randomized controlled trial. Arch Intern Med 2011; 171:460.
          </a>
         </li>
         <li class="breakAll">
          Weiland D. The Program of All-Inclusive Care for the Elderly (PACE). In: The Encyclopedia of Aging, 4th ed, Schultz R, Neolker L, Rockwood K, Sprott R (Eds), Springer, 2006. p.973.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Counsell SR, Callahan CM, Buttar AB, et al. Geriatric Resources for Assessment and Care of Elders (GRACE): a new model of primary care for low-income seniors. J Am Geriatr Soc 2006; 54:1136.
          </a>
         </li>
         <li class="breakAll">
          Robert Graham Center. The patient centered medical home: History, seven core features, evidence, and transformational change. Available at: https://www.graham-center.org/dam/rgc/documents/publications-reports/monographs-books/rgcmo-medical-home.pdf (Accessed on October 19, 2011).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Von Korff M, Katon WJ, Lin EH, et al. Functional outcomes of multi-condition collaborative care and successful ageing: results of randomised trial. BMJ 2011; 343:d6612.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tinetti ME. Making prevention recommendations relevant for an aging population. Ann Intern Med 2010; 153:843.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walter LC, Covinsky KE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA 2001; 285:2750.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lansdorp-Vogelaar I, Gulati R, Mariotto AB, et al. Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits. Ann Intern Med 2014; 161:104.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walter LC, Lewis CL, Barton MB. Screening for colorectal, breast, and cervical cancer in the elderly: a review of the evidence. Am J Med 2005; 118:1078.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin 2006; 56:11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Holmes HM, Min LC, Yee M, et al. Rationalizing prescribing for older patients with multimorbidity: considering time to benefit. Drugs Aging 2013; 30:655.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wolf MS, Shekelle P, Choudhry NK, et al. Variability in pharmacy interpretations of physician prescriptions. Med Care 2009; 47:370.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Giovannetti ER, Wolff JL, Xue QL, et al. Difficulty assisting with health care tasks among caregivers of multimorbid older adults. J Gen Intern Med 2012; 27:37.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Qaseem A, Wilt TJ, Kansagara D, et al. Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians. Ann Intern Med 2018; 168:569.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brown AF, Mangione CM, Saliba D, et al. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc 2003; 51:S265.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 16526 Version 38.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26063472" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18949641" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Multimorbidity in primary care: prevalence and trend over the last 20 years.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20459621" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Prevalence estimates of multimorbidity: a comparative study of two sources.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19287000" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Multimorbidity in primary care: developing the research agenda.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15031310" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17389724" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Report of the national institute on aging task force on comorbidity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Future of multimorbidity research: How should understanding of multimorbidity inform health system design?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18594183" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : From Bedside to Bench: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Comorbidity and Multiple Morbidity in Older Adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18594183" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : From Bedside to Bench: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Comorbidity and Multiple Morbidity in Older Adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11438407" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Problems in determining occurrence rates of multimorbidity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15928225" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Prevalence of multimorbidity among adults seen in family practice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30957230" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Multimorbidity Frameworks Impact Prevalence and Relationships with Patient-Important Outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29726918" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Frailty and Multimorbidity: A Systematic Review and Meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31021126" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : The measurement of multimorbidity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31021126" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : The measurement of multimorbidity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28811281" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Multimorbidity, dementia and health care in older people:a population-based cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22579043" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25220409" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Prevalence of multimorbidity in a geographically defined American population: patterns by age, sex, and race/ethnicity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30790281" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Measuring the burden of multimorbidity among Medicare beneficiaries via condition counts and cumulative duration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29442409" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Socioeconomic status and multimorbidity: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12418941" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Prevalence, expenditures, and complications of multiple chronic conditions in the elderly.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9619963" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21568950" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Informing clinical practice guideline development and implementation: prevalence of coexisting conditions among adults with coronary heart disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20167626" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Chronic conditions account for rise in Medicare spending from 1987 to 2006.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20167626" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Chronic conditions account for rise in Medicare spending from 1987 to 2006.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20167626" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Chronic conditions account for rise in Medicare spending from 1987 to 2006.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17510108" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Multimorbidity's many challenges.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10737690" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Comorbidity of five chronic health conditions in elderly community residents: determinants and impact on mortality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9973071" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Association of comorbidity with disability in older women: the Women's Health and Aging Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9119546" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Co-morbidity analysis: a strategy for understanding mortality, disability and use of health care facilities of older people.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16411033" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Relationship between multimorbidity and health-related quality of life of patients in primary care.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19192038" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : The impact of chronic multimorbidity and disability on functional decline and survival in elderly persons. A community-based, longitudinal study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21436204" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : The prevalence of multimorbidity in primary care and its effect on health care utilization and cost.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19737412" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Prevalence of multiple chronic conditions in the United States' Medicare population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17537089" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : The combined effect of visual impairment and cognitive impairment on disability in older people.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18026807" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Multiple chronic conditions: prevalence, health consequences, and implications for quality, care management, and costs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20837819" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Primary care clinicians' experiences with treatment decision making for older persons with multiple conditions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24038011" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : GPs' perspectives on the management of patients with multimorbidity: systematic review and synthesis of qualitative research.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14749162" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : The end of the disease era.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20371790" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : The challenge of multiple comorbidity for the US health care system.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16091574" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27113155" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Future Research Directions for Multimorbidity Involving Cardiovascular Diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15625341" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Potential pitfalls of disease-specific guidelines for patients with multiple conditions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18026806" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Patient complexity: more than comorbidity. the vector model of complexity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24821897" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : IOM and DHHS meeting on making clinical practice guidelines appropriate for patients with multiple chronic conditions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24442331" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Evidence-based medicine and the hard problem of multimorbidity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24442332" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : A framework for crafting clinical practice guidelines that are relevant to the care and management of people with multimorbidity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24442334" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Addressing multimorbidity in evidence integration and synthesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24442333" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Multimorbidity and evidence generation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23713595" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Impact of co-morbidities on self-rated health in self-reported COPD: an analysis of NHANES 2001-2008.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23256171" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : How to integrate multiple comorbidities in guideline development: article 10 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22870234" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Informing evidence-based decision-making for patients with comorbidity: availability of necessary information in clinical trials for chronic diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23106132" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Diabetes in older adults: a consensus report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25538310" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32389227" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Informing Patient-Centered Care Through Stakeholder Engagement and Highly Stratified Quantitative Benefit-Harm Assessments.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33196766" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Evaluation of Time to Benefit of Statins for the Primary Prevention of Cardiovascular Events in Adults Aged 50 to 75 Years: A Meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21343220" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Shifting priorities in multimorbidity: a longitudinal qualitative study of patient's prioritization of multiple conditions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22091493" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Categorizing the effect of comorbidity: a qualitative study of individuals' experiences in a low-vision rehabilitation program.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12660210" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Primary care: is there enough time for prevention?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15928223" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Is there time for management of patients with chronic diseases in primary care?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25733718" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Polypharmacy Among Adults Aged 65 Years and Older in the United States: 1988-2010.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Potentially inappropriate medication use: Prevalence and association with resource utilization in an elderly managed care population
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18179993" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Polypharmacy in elderly patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16582875" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9374881" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Medicine based evidence, a prerequisite for evidence based medicine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19220562" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Missing data: a special challenge in aging research.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16569712" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Randomized controlled trials: do they have external validity for patients with multiple comorbidities?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31711480" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Representation of people with comorbidity and multimorbidity in clinical trials of novel drug therapies: an individual-level participant data analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33448337" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Interventions for improving outcomes in patients with multimorbidity in primary care and community settings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17389725" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Methodology, design, and analytic techniques to address measurement of comorbid disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14607386" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Comorbidity: implications for research and practice in geriatric oncology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22994865" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Guiding principles for the care of older adults with multimorbidity: an approach for clinicians: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30663782" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Decision Making for Older Adults With Multiple Chronic Conditions: Executive Summary for the American Geriatrics Society Guiding Principles on the Care of Older Adults With Multimorbidity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27655884" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Clinical assessment and management of multimorbidity: summary of NICE guidance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12026006" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : A user's manual for the IOM's 'Quality Chasm' report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11032203" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : The impact of patient-centered care on outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16686804" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Views of older adults on patient participation in medication-related decision making.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20121994" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Better ways to care for older persons: is anybody listening?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17000937" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : The care transitions intervention: results of a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15006832" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Adverse events due to discontinuations in drug use and dose changes in patients transferred between acute and long-term care facilities.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12911647" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Medical errors related to discontinuity of care from an inpatient to an outpatient setting.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12657078" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Falling through the cracks: challenges and opportunities for improving transitional care for persons with continuous complex care needs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12236382" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Understanding coordination of care from the consumer's perspective in a regional health system.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16702590" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Systematic review: impact of health information technology on quality, efficiency, and costs of medical care.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17568035" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Information technology comes to medicine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17766512" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Practice-based care coordination: a medical home essential.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10968308" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : The effect of case management on the costs of health care for enrollees in Medicare Plus Choice plans: a randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18625921" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Hidden in plain sight: medical visit companions as a resource for vulnerable older adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17052336" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Perceived conflict in the couple and chronic illness management: preliminary analyses from the Quebec Health Survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20308348" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Family influences on self-management among functionally independent adults with diabetes or heart failure: do family members hinder as much as they help?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20063128" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Family caregivers, patients and physicians: ethical guidance to optimize relationships.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19350877" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Optimizing patient and family involvement in geriatric home care.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10345255" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Chronic disease management: what will it take to improve care for chronic illness?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21045100" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Comprehensive primary care for older patients with multiple chronic conditions: "Nobody rushes you through".
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26833209" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Medical Assistant-Based Care Management for High-Risk Patients in Small Primary Care Practices: A Cluster Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17989412" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Guided care for multimorbid older adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20033622" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : The effects of guided care on the perceived quality of health care for multi-morbid older persons: 18-month outcomes from a cluster-randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21403043" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : The effect of guided care teams on the use of health services: results from a cluster-randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21403043" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : The effect of guided care teams on the use of health services: results from a cluster-randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16866688" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Geriatric Resources for Assessment and Care of Elders (GRACE): a new model of primary care for low-income seniors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16866688" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Geriatric Resources for Assessment and Care of Elders (GRACE): a new model of primary care for low-income seniors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22074851" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Functional outcomes of multi-condition collaborative care and successful ageing: results of randomised trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21173418" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Making prevention recommendations relevant for an aging population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11386931" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Cancer screening in elderly patients: a framework for individualized decision making.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25023249" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16194635" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Screening for colorectal, breast, and cervical cancer in the elderly: a review of the evidence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16449183" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : American Cancer Society guidelines for the early detection of cancer, 2006.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23749475" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Rationalizing prescribing for older patients with multimorbidity: considering time to benefit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19194338" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Variability in pharmacy interpretations of physician prescriptions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21874385" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Difficulty assisting with health care tasks among caregivers of multimorbid older adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29507945" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12694461" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Guidelines for improving the care of the older person with diabetes mellitus.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
